Mom-to-be-women, pay attention! Intake of indigestion medications during pregnancy can prompt the threat of asthma among your newborn kids. The survey, conducted by the team of analysts from the University of Edinburgh in the UK and the revealed that infants whose moms had been prescribed with heartburn pills to heal acid reflux during pregnancy time are more prone to the attack of asthma in their infancy.
In the study report, the researchers also suggested that one-third of the mothers who had gone through heartburn medications during their pregnancy are more likely to deliver kids with asthma symptoms. However, up till now, it continues to be unclear if the drugs itself or some other factors are liable to the increased risk of asthma among kids, confirmed the researchers in their study, published in the Journal of Allergy and Clinical Immunology.
For completing the study, the investigators conducted a total of eight types of research that involved more than 1.3 million kids. During the survey, the researchers discovered that the children who born to moms who were prescribed heartburn pills for treating acid reflux during their pregnancy were are under higher risks of asthma. At least one-third of such children were found to be suffered from the asthma symptoms. The researchers also stated that the category of stomachache medications that includes Tagamet, Zantac, Prilosec, Nexium and Pepcid are riskier for the pregnant women and their newborn infants.
According to Dr. Aziz Sheikh, the co-director of the Asthma UK Center for Applied Research, at the University of Edinburgh in Scotland, “Our research marks a serious link between the origin of asthma in brood and their mothers, who were prescribed to use acid-suppressing medicine during pregnancy. After analyzing all the data and reports, we found the acid-suppressing medicines and kids with asthma are somehow connected. However, we are not confirming those medicines to be the prime cause of asthma in these children. The possibilities for the existence of some other external factors for the disease can’t be denied and further study is needed to identify more with this link.”
The study report was published online, in the Journal of Allergy and Clinical Immunology, on 9th January 2017, Monday.